STOCK TITAN

IT Tech Packaging, Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements

(Neutral)
(Very Negative)
Tags

IT Tech Packaging (NYSE American: ITP) received a notice of noncompliance from NYSE Regulation for failing to timely file its Form 10-K for year ended December 31, 2025 by the April 15, 2026 deadline. The NYSE American Notice does not immediately affect trading.

The company cited inability to finalize financial results and said it intends to file the Delinquent Report within the six-month cure period and to regain compliance, but there is no assurance compliance will be restored.

Loading...
Loading translation...

Positive

  • NYSE provides an Initial Cure Period of up to six months
  • Company intends to file the Delinquent Report as soon as practicable

Negative

  • Failed to file Form 10-K for year ended December 31, 2025 by April 15, 2026
  • Risk of suspension and delisting if delinquency is not cured within cure periods
  • Delay due to inability to finalize financial results and disclosures

News Market Reaction – ITP

-7.41%
4 alerts
-7.41% Session close to close
-4.7% Trough Tracked
$3.50M Market Cap
0.1x Rel. Volume

In the Apr 21 session, ITP declined 7.41%, reflecting a notable negative market reaction. Argus tracked a trough of -4.7% from its starting point during tracking. Our momentum scanner triggered 4 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved -7.4% in the session following this news. A negative reaction despite the absence of...
Analysis

The stock moved -7.4% in the session following this news. A negative reaction despite the absence of immediate delisting would fit concerns about recurring reporting and going-concern issues. The stock traded near its $0.151 52-week low and 79.6% below its high before this notice, so added listing uncertainty could weigh heavily. Prior governance news on October 31, 2025 coincided with a 4.58% drop, suggesting sensitivity to corporate and regulatory updates rather than operating improvements.

Key Figures

10-K period end: December 31, 2025 10-K due date: April 15, 2026 Late-filing notice date: March 31, 2026 +5 more
8 metrics
10-K period end December 31, 2025 Fiscal year covered by Delinquent Report
10-K due date April 15, 2026 Original SEC filing deadline for Form 10-K
Late-filing notice date March 31, 2026 Form 12b-25 Notification of Late Filing
Press release deadline 5 days Time after NYSE delinquency notice to issue disclosure
Initial Cure Period 6 months First NYSE cure window from Filing Delinquency date
Additional Cure Period 6 months Potential extra NYSE cure window at NYSE discretion
Current price $0.204 Pre-news price reference with article context
52-week range $0.151 – $1.00 ITP 52-week low and high before this notice

Historical Context

1 past event · Latest: Oct 31 (Neutral)
Pattern 1 events
Date Event Sentiment 24h Move Catalyst
Oct 31 Annual meeting results Neutral -4.6% Shareholders approved directors, auditor and 2025 equity plan at annual meeting.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Limited history shows one prior governance/meeting event where the stock fell despite neutral-to-routine news.

Recent Company History

Over the last six months, ITP’s disclosed events were mainly governance and reporting related. An October 31, 2025 Annual General Meeting confirmed directors, ratified the auditor, and approved a 2025 equity incentive plan, yet the stock fell 4.58% the next day. Today’s NYSE American non-compliance notice continues a pattern of reporting and listing-status developments dominating the news flow, against a backdrop of going concern language in prior filings.

Key Terms

form 10-k, nyse american, company guide, initial cure period, +2 more
6 terms
form 10-k regulatory
"failure to timely file the Company's Form 10-K for the year ended"
A Form 10-K is a comprehensive report that publicly traded companies are required to file annually with regulators. It provides a detailed overview of a company's financial health, operations, and risks, similar to a detailed health report. Investors use this information to assess the company's performance and make informed decisions about buying or selling its stock.
nyse american regulatory
"notice of noncompliance with NYSE American continued listing standards"
NYSE American is a stock exchange where companies can list their shares to be bought and sold by investors. It functions like a marketplace, helping businesses raise money and providing investors with opportunities to buy ownership in these companies. Its role is important because it facilitates the trading of smaller or emerging companies, offering investors access to a broader range of investment options.
company guide regulatory
"Section 1007 of the NYSE American Company Guide (the "Company Guide")"
A company guide is a concise profile that explains what a business does, how it makes money, and the key risks and opportunities investors should know. Think of it as a one-page briefing or travel brochure for the firm that helps readers quickly understand the company’s strategy, products, markets and financial outlook so they can compare it to other investments without digging through long reports.
initial cure period regulatory
"During the six-month period from the date of the Filing Delinquency (the "Initial Cure Period")"
A specified window of time given to a party under a contract to fix a problem or comply with an obligation before the other side can take stronger steps like stopping performance, seeking damages, or terminating the agreement. For investors it matters because the length and conditions of that grace period affect how quickly disputes can escalate, the likelihood of contract continuity, and potential financial or operational disruptions—think of it as a formal grace period to repair a leak before deciding whether to replace the roof.
additional cure period regulatory
"up to an additional six-month period (the "Additional Cure Period") depending"
An additional cure period is extra time written into a contract that lets a party fix a breach or missed payment before the other side can take harsh steps like ending the deal or calling a loan due. For investors, it matters because it can delay or prevent immediate losses, affect the timing of recoveries, and signal how quickly negative events might hit a company’s cash flow or share value—like a grace period to repair a leaky pipe before eviction.
form 12b-25 regulatory
"Notification of Late Filing on Form 12b-25 (filed with the SEC on March 31, 2026)"
Form 12b-25 is a notice a publicly traded company files with the U.S. Securities and Exchange Commission when it cannot deliver a required periodic report (like a quarterly or annual financial report) on time. It explains the reason for the delay and gives the company a short, temporary window to finish the report without being marked as delinquent; investors watch it because late filings can signal accounting, operational, or control issues that may affect a company’s reliability and stock risk, much like a missed homework deadline can raise concerns about a student’s preparedness.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

BAODING, China, April 20, 2026 /PRNewswire/ -- IT Tech Packaging Inc. (NYSE American: ITP) ("IT Tech Packaging" or the "Company"), a leading manufacturer and distributor of diversified paper products in North China, received an official notice of noncompliance (the "NYSE American Notice") from NYSE Regulation ("NYSE") stating that the Company is not in compliance with NYSE American continued listing standards (the "Filing Delinquency Notification") due to the failure to timely file the Company's Form 10-K for the year ended December 31, 2025 (the "Delinquent Report") by the filing due date of April 15, 2026 (the "Filing Delinquency").

The Company is now subject to the procedures and requirements set forth in Section 1007 of the NYSE American Company Guide (the "Company Guide"). Within five days of the date of the Filing Delinquency Notification, the Company was required to (a) contact the NYSE to discuss the status of the Delinquent Report and (b) issue a press release disclosing the occurrence of the Filing Delinquency, the reason for the Filing Delinquency and, if known, the anticipated date such Filing Delinquency will be cured via the filing or refiling of the applicable report, as the case may be. The NYSE American Notice has no immediate effect on the listing or trading of the Company's common stock on NYSE American.

During the six-month period from the date of the Filing Delinquency (the "Initial Cure Period"), the NYSE will monitor the Company and the status of the Delinquent Report and any subsequent delayed filings, including through contact with the Company, until the Filing Delinquency is cured. If the Company fails to cure the Filing Delinquency within the Initial Cure Period, the NYSE may, in the NYSE's sole discretion, allow the Company's securities to be traded for up to an additional six-month period (the "Additional Cure Period") depending on the Company's specific circumstances. If the NYSE determines that an Additional Cure Period is not appropriate, suspension and delisting procedures will commence in accordance with the procedures set out in Section 1010 of the Company Guide. If the NYSE determines that an Additional Cure Period of up to six months is appropriate and the Company fails to file its Delinquent Report and any subsequent delayed filings by the end of that period, suspension and delisting procedures will generally commence.

Notwithstanding the foregoing, however, the NYSE may in its sole discretion decide (i) not to afford the Company any Initial Cure Period or Additional Cure Period, as the case may be, at all or (ii) at any time during the Initial Cure Period or Additional Cure Period, to truncate the Initial Cure Period or Additional Cure Period, as the case may be, and immediately commence suspension and delisting procedures if the Company is subject to delisting pursuant to any other provision of the Company Guide, including if the NYSE believes, in the NYSE's sole discretion, that continued listing and trading of the Company's securities on the NYSE is inadvisable or unwarranted in accordance with Sections 1001-1006 of the Company Guide.

Reference is made to the Company's Notification of Late Filing on Form 12b-25 (filed with the SEC on March 31, 2026), which described the circumstances leading to the late filing of the Delinquent Report. The Delinquent Report could not be filed within the prescribed time period due to the fact that the Company was unable to finalize its financial results as well as the disclosure requirements of the Delinquent Report without unreasonable expense or effort. As a result, the Company could not solicit and obtain the necessary review of the Delinquent Report in a timely fashion prior to the due date of the Delinquent Report. Additional time is needed by the Company to complete its review of the financial statements included in the Delinquent Report to ensure a complete, accurate Delinquent Report. The Company intends to file the Delinquent Report as soon as practicable and in any event within the six-month period.

The Company intends to regain compliance with the NYSE American continued listing standards. There can be no assurance that the Company will ultimately regain compliance with all applicable NYSE American listing standards.

About IT Tech Packaging, Inc.

Founded in 1996, IT Tech Packaging, Inc. is a leading manufacturer and distributor of diversified paper products in North China. Using recycled paper as its primary raw material (with the exception of its tissue paper products), ITP produces and distributes three categories of paper products: corrugating medium paper, offset printing paper and tissue paper products. With production based in Baoding and Xingtai in North China's Hebei Province, ITP is located strategically close the Beijing and Tianjin region, home to a growing base of industrial and manufacturing activities and one of the largest markets for paper products consumption in the country. ITP has been listed on the NYSE American since December 2009. For more information, please visit: www.itpackaging.cn

Forward-Looking Statements

This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Certain of these forward-looking statements can be identified by the use of words such as "believes," "expects," "intends," "plans," "estimates," "assumes," "may," "should," "will," "seeks," or other similar expressions. Such statements may include, but are not limited to, statements regarding the Company's plan to file the Delinquent Report within the Initial Cure Period to regain compliance with the NYSE American continued listing standards. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. Factors that may cause such differences include, without limitation, the Company's ability to file the Delinquent Report within the Initial Cure Period to regain compliance with the NYSE American continued listing standards, and other risks and uncertainties indicated from time to time in filings with the Securities and Exchange Commission ("SEC"), including the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, under the heading "Risk Factors," and other documents the Company has filed, or will file, with the SEC. Readers are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.

Contacts:

At the Company Email:

ir@itpackaging.cn
Tel: +86 0312 8698215

Cision View original content:https://www.prnewswire.com/news-releases/it-tech-packaging-inc-announces-receipt-of-notice-of-non-compliance-with-nyse-continued-listing-requirements-302746782.html

SOURCE IT Tech Packaging, Inc

FAQ

Why did IT Tech Packaging (ITP) receive a NYSE noncompliance notice on April 20, 2026?

Because the company failed to file its Form 10-K for the year ended December 31, 2025 by the April 15, 2026 deadline. According to the company, the Delinquent Report could not be finalized without unreasonable expense or effort, delaying required reviews.

Does the NYSE notice affect trading of IT Tech Packaging (ITP) shares immediately?

No, the NYSE American Notice has no immediate effect on trading of ITP shares. According to the company, NYSE will monitor the delinquency and may allow an Initial Cure Period before suspension or delisting procedures commence.

What timeline does IT Tech Packaging have to cure the filing delinquency for ITP?

The company has up to a six-month Initial Cure Period to file the Delinquent Report, potentially extendable by six months. According to the company, NYSE may grant an Additional Cure Period or commence delisting if warranted.

What reason did IT Tech Packaging give for the late Form 10-K filing for 2025?

The company said it could not finalize financial results and required disclosures in time without unreasonable expense or effort. According to the company, additional time is needed to complete reviews to ensure a complete, accurate filing.

What are the investor risks if IT Tech Packaging (ITP) does not cure the filing delinquency?

Investors face potential suspension and delisting of ITP shares if filings are not completed within cure periods. According to the company, NYSE may also truncate cure periods or begin delisting procedures if continued listing is deemed inadvisable.